Reply to: RAAS inhibitors in COVID-19: Not all are created equal!

被引：3
|
作者：
Goncalves, Jorge [1 ,2 ]
Santos, Catarina D. [1 ]
Fresco, Paula [1 ,2 ]
Fernandez-Llimos, Fernando [1 ,2 ]
机构：
[1] Univ Porto, Fac Farm, Lab Farmacol, Porto, Portugal
[2] Univ Porto, Fac Pharm, Mechanist Pharmacol & Pharmacotherapy Unit, UCIBIO i4HB, Porto, Portugal
来源：
REVISTA PORTUGUESA DE CARDIOLOGIA | 2023年 / 42卷 / 09期
关键词：
TELMISARTAN; REDUCE;
D O I：
10.1016/j.repc.2023.06.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 818
页数：2
相关论文
共 50 条
  • [1] Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
    Goncalves, Jorge
    Santos, Catarina D.
    Fresco, Paula
    Fernandez-Llimos, Fernando
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (04) : 221 - 222
  • [2] RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
    Rothlin, Rodolfo P.
    Pelorosso, Facundo
    Duarte, Mariano
    Nicolosi, Liliana
    Criado, Ignacio Fernandez
    Salgado, Maria Victoria
    Vetulli, Hector
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (04) : 219 - 220
  • [3] RAAS inhibitors in COVID-19: They are not all the same!
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (09) : 815 - 816
  • [4] RAAS Inhibitors and Risk of Covid-19 REPLY
    Reynolds, Harmony R.
    Adhikari, Samrachana
    Iturrate, Eduardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1993 - 1994
  • [5] RAAS Inhibitors and Risk of Covid-19
    Strauss, Martin H.
    Hall, Alistair S.
    Lavie, Carl J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1992 - 1993
  • [6] Not all worries were created equal: the case of COVID-19 anxiety
    Maaravi, Y.
    Heller, B.
    PUBLIC HEALTH, 2020, 185 : 243 - 245
  • [7] RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
    Holmes, Adam R.
    Nelson, Jacob
    Hirschl, Jacob
    Perkins, Sidney J.
    Chopra, Zoey
    Fung, Christopher
    Medlin, Richard P., Jr.
    Korley, Frederick K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3073 - 3073
  • [8] COVID-19 and RAAS inhibitors: is there a final conclusion?
    Talebi-Taher, Mahshid
    Najafi, Mohammad Hosein
    Behzad, Shima
    IRANIAN JOURNAL OF MICROBIOLOGY, 2021, 13 (06) : 728 - 736
  • [9] Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’
    Ying-Ying Zheng
    Yi-Tong Ma
    Jin-Ying Zhang
    Xiang Xie
    Nature Reviews Cardiology, 2020, 17 : 313 - 314
  • [10] RAAS inhibitors do not increase the risk of COVID-19
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (07) : 383 - 383
12345